Tag Archives: GlaxoSmithKline PLC

Top Stories for Week of September 7, 2020

      No Comments on Top Stories for Week of September 7, 2020

Pfizer sees data for COVID-19 vaccine’s efficacy by end of October. Amid the frantic race for a COVID-19 vaccine, Pfizer may have early efficacy results in just a matter of weeks. During a digital event Thursday,… Read more »

Top Stories for Week of August 3, 2020

      No Comments on Top Stories for Week of August 3, 2020

SARS CoV-2 showing no signs of backing off in US, while Fauci, GOP lawmakers quarrel at hearing. Florida, one of the US coronavirus hotspots, reported another record increase in COVID-19… Read more »

Top Stories for Week of June 1, 2020

      No Comments on Top Stories for Week of June 1, 2020

US coronavirus deaths top 100,000 as country reopens; Trump cuts ties with WHO. President Donald Trump on Thursday offered his first expression of sympathy in observance of the milestone of… Read more »

FDA goes on a rulings binge

      No Comments on FDA goes on a rulings binge

FDA ROUNDUP: In one of the busiest rulings binges of the year, the US Food and Drug Administration last week approved an assortment of pharmaceuticals, medical devices, an AI algorithm… Read more »

England’s biotech startup Sitryx out of the blocks with new I/O program. Stakes are high as Europe’s science contending with US for top global developers.

      No Comments on England’s biotech startup Sitryx out of the blocks with new I/O program. Stakes are high as Europe’s science contending with US for top global developers.

The News: Sitryx Therapeutics Ltd. (London) has launched with the goal of treating cancer and inflammatory conditions by targeting the metabolism of immune cells, a promising new area of research…. Read more »

India’s huge pharma/consumer health market in crosshairs of world’s biggest drugmakers. China, Japan, Korea lurking as Asia joins fray with West.

      No Comments on India’s huge pharma/consumer health market in crosshairs of world’s biggest drugmakers. China, Japan, Korea lurking as Asia joins fray with West.

The News: GlaxoSmithKline PLC‘s (London) Indian consumer health unit is drawing the attention of more big-name suitors as the magnitude of the potential there is coming into clearer focus. After… Read more »

ViiV Healthcare’s success with monthly combo HIV med making Gilead sweat over its HIV franchise. After World Cup fiasco, England chasing California in $$$$/rep race.

      No Comments on ViiV Healthcare’s success with monthly combo HIV med making Gilead sweat over its HIV franchise. After World Cup fiasco, England chasing California in $$$$/rep race.

The News: GlaxoSmithKline PLC’s (London) ViiV Healthcare unit now has results to support a two-drug monthly injection co-developed with Johnson & Johnson (New Brunswick NJ) as it pushes ahead with its ambition… Read more »

China’s FDA to accept foreign trial data for accelerated approvals; sounds great, but future enforcement of IP rights poses threat to US Pharma.

      No Comments on China’s FDA to accept foreign trial data for accelerated approvals; sounds great, but future enforcement of IP rights poses threat to US Pharma.

The News: For decades, patients in China have fought to gain access to cutting-edge medicines thanks to bureaucratic delays that have thwarted drug development. Now a sweeping government overhaul of… Read more »

FDA’s Gottlieb continues to amaze, turning agency into pharma-friendly ally.

      No Comments on FDA’s Gottlieb continues to amaze, turning agency into pharma-friendly ally.

The News: The US Food and Drug Administration on Monday (October 2, 2017) announced a series of measures designed to speed to market generic versions of complex drugs such as… Read more »

Germany’s Merck puts consumer drugs business up for sale; does this signal a last-ditch shot at M&A or just shoring up existing pipeline?

      No Comments on Germany’s Merck puts consumer drugs business up for sale; does this signal a last-ditch shot at M&A or just shoring up existing pipeline?

The News: Merck KGaA (Darmstadt DEU) put its consumer-health unit on the block Tuesday (September 5, 2017) in a move that will focus its healthcare activities on the riskier business… Read more »